Unicycive Therapeutics Inc

NASDAQ:UNCY   4:00:00 PM EDT
0.71
-0.01 (-1.04%)
Products

Unicycive Reports Key Findings Of Uni-494 Efficacy In Preclinical Animal Model Of Geographic Atrophy

Published: 11/21/2022 12:15 GMT
Unicycive Therapeutics Inc (UNCY) - Unicycive Reports Key Findings of Uni-494 Efficacy in Preclinical Animal Model of Geographic Atrophy.
Unicycive Therapeutics Inc - Treatment With Uni-494 Improved Contrast Vision in Animal Models of Geographic Atrophy (ga).
Unicycive Therapeutics Inc - Co Remains on Track to Initiate a Phase I Study in Healthy Volunteers During Q1 of 2023 in Uk.